185 related articles for article (PubMed ID: 30186187)
1. Safety Challenges of Using High Dose Baclofen for Alcohol Use Disorder: A Focused Review.
Rolland B; Simon N; Franchitto N
Front Psychiatry; 2018; 9():367. PubMed ID: 30186187
[TBL] [Abstract][Full Text] [Related]
2. The Use of Baclofen as a Treatment for Alcohol Use Disorder: A Clinical Practice Perspective.
de Beaurepaire R; Sinclair JMA; Heydtmann M; Addolorato G; Aubin HJ; Beraha EM; Caputo F; Chick JD; de La Selle P; Franchitto N; Garbutt JC; Haber PS; Jaury P; Lingford-Hughes AR; Morley KC; Müller CA; Owens L; Pastor A; Paterson LM; Pélissier F; Rolland B; Stafford A; Thompson A; van den Brink W; Leggio L; Agabio R
Front Psychiatry; 2018; 9():708. PubMed ID: 30662411
[TBL] [Abstract][Full Text] [Related]
3. Phone-based safety monitoring of the first year of baclofen treatment for alcohol use disorder: the BACLOPHONE cohort study protocol.
Rolland B; Auffret M; Labreuche J; Lapeyre-Mestre M; Dib M; Kemkem A; Grit I; Drelon M; Duhamel A; Cabe N; Vabret F; Guillin O; Baguet A; Masquelier C; Dervaux A; Deheul S; Bordet R; Carton L; Cottencin O; Jardri R; Gautier S
Expert Opin Drug Saf; 2017 Feb; 16(2):125-132. PubMed ID: 27984918
[TBL] [Abstract][Full Text] [Related]
4. Safety reports on the off-label use of baclofen for alcohol-dependence: recommendations to improve causality assessment.
Rolland B; Auffret M; Franchitto N
Expert Opin Drug Saf; 2016 Jun; 15(6):747-51. PubMed ID: 26987987
[TBL] [Abstract][Full Text] [Related]
5. Baclofen-induced manic symptoms: case report and systematic review.
Geoffroy PA; Auffret M; Deheul S; Bordet R; Cottencin O; Rolland B
Psychosomatics; 2014; 55(4):326-332. PubMed ID: 24751117
[TBL] [Abstract][Full Text] [Related]
6. Severe tinnitus induced by off-label baclofen.
Auffret M; Rolland B; Deheul S; Loche V; Hennaux C; Cottencin O; Bordet R; Gautier S;
Ann Pharmacother; 2014 May; 48(5):656-9. PubMed ID: 24577148
[TBL] [Abstract][Full Text] [Related]
7. Baclofen in the treatment of alcohol use disorder: tailored doses matter.
de Beaurepaire R; Jaury P
Alcohol Alcohol; 2024 Jan; 59(2):. PubMed ID: 38266071
[TBL] [Abstract][Full Text] [Related]
8. Proactive Regional Pharmacovigilance System Versus National Spontaneous Reporting for Collecting Safety Data on Concerning Off-Label Prescribing Practices: An Example with Baclofen and Alcohol Dependence in France.
Auffret M; Labreuche J; Duhamel A; Deheul S; Cottencin O; Bordet R; Gautier S; Rolland B
Drug Saf; 2017 Mar; 40(3):257-262. PubMed ID: 27988884
[TBL] [Abstract][Full Text] [Related]
9. A Review of the Potential Mechanisms of Action of Baclofen in Alcohol Use Disorder.
de Beaurepaire R
Front Psychiatry; 2018; 9():506. PubMed ID: 30459646
[TBL] [Abstract][Full Text] [Related]
10. Assessing alcohol versus baclofen withdrawal syndrome in patients treated with baclofen for alcohol use disorder.
Rolland B; Jaillette E; Carton L; Bence C; Deheul S; Saulnier F; Bordet R; Cottencin O
J Clin Psychopharmacol; 2014 Feb; 34(1):153-6. PubMed ID: 24346755
[TBL] [Abstract][Full Text] [Related]
11. Baclofen in the Treatment of Patients With Alcohol Use Disorder and Other Mental Health Disorders.
Agabio R; Leggio L
Front Psychiatry; 2018; 9():464. PubMed ID: 30323774
[TBL] [Abstract][Full Text] [Related]
12. Full-Profile Pharmacokinetic Study of High Dose Baclofen in Subjects With Alcohol Use Disorder.
Simon N; Moirand R; Dematteis M; Bordet R; Deplanque D; Rolland B
Front Psychiatry; 2018; 9():385. PubMed ID: 30190685
[TBL] [Abstract][Full Text] [Related]
13. The safety and efficacy of baclofen to reduce alcohol use in veterans with chronic hepatitis C: a randomized controlled trial.
Hauser P; Fuller B; Ho SB; Thuras P; Kern S; Dieperink E
Addiction; 2017 Jul; 112(7):1173-1183. PubMed ID: 28192622
[TBL] [Abstract][Full Text] [Related]
14. Baclofen in alcohol use disorder: An analysis of the data provided by the French "Temporary Recommendation for Use" 2014-2017 cohort.
de Beaurepaire R; Rolland B
Front Psychiatry; 2022; 13():949750. PubMed ID: 36311508
[TBL] [Abstract][Full Text] [Related]
15. Successful Management of Gamma-hydroxybutyrate (GHB) Withdrawal Using Baclofen as a Standalone Therapy: A Case Report.
Habibian S; Ahamad K; McLean M; Socias ME
J Addict Med; 2019; 13(5):415-417. PubMed ID: 30907765
[TBL] [Abstract][Full Text] [Related]
16. Baclofen for the Treatment of Alcohol Use Disorder in Patients With Liver Cirrhosis: 10 Years After the First Evidence.
Mosoni C; Dionisi T; Vassallo GA; Mirijello A; Tarli C; Antonelli M; Sestito L; Rando MM; Tosoni A; De Cosmo S; Gasbarrini A; Addolorato G
Front Psychiatry; 2018; 9():474. PubMed ID: 30327620
[TBL] [Abstract][Full Text] [Related]
17. Baclofen and severe alcohol dependence: an uncertain harm-benefit balance as of early 2013.
Prescrire Int; 2013 Sep; 22(141):214-7. PubMed ID: 24171218
[TBL] [Abstract][Full Text] [Related]
18. Is baclofen a revolutionary medication in alcohol addiction management? Review and recent updates.
Gorsane MA; Kebir O; Hache G; Blecha L; Aubin HJ; Reynaud M; Benyamina A
Subst Abus; 2012; 33(4):336-49. PubMed ID: 22989277
[TBL] [Abstract][Full Text] [Related]
19. Baclofen Abuse due to Its Hypomanic Effect in Patients with Alcohol Dependence and Comorbid Major Depressive Disorder.
Ghosh S; Bhuyan D
Clin Psychopharmacol Neurosci; 2017 May; 15(2):187-189. PubMed ID: 28449569
[TBL] [Abstract][Full Text] [Related]
20. Efficacy, tolerability, and safety of low-dose and high-dose baclofen in the treatment of alcohol dependence: A systematic review and meta-analysis.
Pierce M; Sutterland A; Beraha EM; Morley K; van den Brink W
Eur Neuropsychopharmacol; 2018 Jul; 28(7):795-806. PubMed ID: 29934090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
